Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Pharyngeal cancer
Open
Phase 1/2
This trial is looking at adding certain targeted drugs to radiotherapy for head and neck cancer. Some parts of the trial are also looking at these treatments with immunotherapy.
The trial is for people who have one of the following types of head and neck cancer:
cancer of the area that surrounds the voice box ()
cancer of the voice box (laryngeal cancer)
Recruitment start: 5 September 2021
Recruitment end: 5 January 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Anthony Kong
AstraZeneca
University of Birmingham
Last reviewed: 24 Sept 2025
CRUK internal database number: 18055
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
